Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,212 Cr₹997 Cr₹773 Cr₹773 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹1,212 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹1,212 Cr
Mar2022₹997 Cr
Mar2021₹773 Cr
Mar2020₹773 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr
29.00
Mar2021 ₹773 Cr
0.00
Mar2020 ₹773 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,732.2 Cr -1% -6.6% 25.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹115,034.0 Cr 1% -5% 53.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.1% 2.2% 26% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr 3.2% 15.3% 23.6% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 3.9% -1.7% 85.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1%

-6.6%

25.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses